Feletto Eleonora, Sitas Freddy
Cancer Research Division, Cancer Council NSW, 153 Dowling St, Woolloomooloo, NSW, 2011, Australia.
University of Sydney, School of Public Health, Sydney, Australia.
BMC Public Health. 2015 Aug 26;15:823. doi: 10.1186/s12889-015-2141-3.
In 2013, about 32% of the Australian population over 15 years of age was born overseas. Previous cancer-related immigrant health studies identified differences in mortality and incidence between immigrants and Australian-born people. To identify groups that may require targeted interventions, we describe by region of birth: 1. the highest cancer incidence and mortality rates for NSW residents, Australia's most populous state; and 2. mortality to incidence ratios (MIR) for all cancers.
Cancer incidence and mortality data were obtained from NSW residents for 2004-2008 (averaged) by sex, region of birth and 10 year age groups. Age standardised incidence and mortality rates were calculated with 95% confidence intervals (per 100,000), using the world standard population. In the place of 5-year survival rates, we used age standardised MIRs (=M/I) as a simple proxy indicator of cancer survival.
All-cancer incidence only exceeded Australian born people (308.5) for New Zealand born (322). The highest reported incidence rates for cancers from all regions were prostate and breast cancers. All-cancer mortality exceeded Australian-born (105.3) in people born in Western Europe (110.9), Oceania (108.2) and UK and Ireland (106.4). For Australian-born residents, the MIR was 34 cancer deaths per 100 cases compared to residents from Central Europe at 38 deaths per 100 cases and lowest at 28 deaths per 100 cases for residents from Central and Southern Asia.
Some disparities between Australian-born NSW residents and immigrants were identified in prostate, breast and lung cancer mortality rates. While on average most immigrant groups have similar cancer characteristics for the top cancers, areas for improvement to inform strategies to alleviate cancer disparities are required. This analysis suggests that NSW residents could benefit from specific prevention programmes on healthy eating and smoking cessation, especially people from Central Europe, UK and Ireland and Western Europe. Rising immigration rates encourage us to continue to address the areas indicated for improvement.
2013年,澳大利亚15岁以上人口中约32%出生在海外。以往与癌症相关的移民健康研究发现,移民与澳大利亚出生的人在死亡率和发病率上存在差异。为了确定可能需要有针对性干预的群体,我们按出生地区描述:1. 澳大利亚人口最多的新南威尔士州(NSW)居民中癌症发病率和死亡率最高的情况;2. 所有癌症的死亡率与发病率之比(MIR)。
通过性别、出生地区和10岁年龄组,获取了新南威尔士州居民2004 - 2008年(平均)的癌症发病率和死亡率数据。使用世界标准人口计算年龄标准化发病率和死亡率,并给出95%置信区间(每10万人)。我们使用年龄标准化的MIRs(=M/I)作为癌症生存率的一个简单替代指标,而不是5年生存率。
仅新西兰出生的人(322)的所有癌症发病率超过澳大利亚出生的人(308.5)。所有地区报告的癌症发病率最高的是前列腺癌和乳腺癌。出生在西欧(110.9)、大洋洲(108.2)以及英国和爱尔兰(106.4)的人的所有癌症死亡率超过澳大利亚出生的人(105.3)。对于澳大利亚出生的居民,MIR为每100例癌症中有34例死亡,而中欧居民为每100例中有38例死亡,中南亚居民最低,为每100例中有28例死亡。
在前列腺癌、乳腺癌和肺癌死亡率方面,澳大利亚出生的新南威尔士州居民与移民之间存在一些差异。虽然平均而言,大多数移民群体在主要癌症方面具有相似的癌症特征,但仍需要改进一些方面,以制定减轻癌症差异的策略。该分析表明,新南威尔士州居民可能会从关于健康饮食和戒烟的特定预防计划中受益,特别是来自中欧、英国和爱尔兰以及西欧的人。不断上升的移民率促使我们继续关注所指出的需要改进的领域。